AstraZeneca has launched a photo-sharing campaign on Twitter, Instagram and other social media sites to get women talking about their metastatic breast cancer (MBC).
The explosion in online discussions about medicines and the rise of social-listening tools to mine and analyze the data have given drugmakers another way to learn what patients think about their products. But pharma companies aren't the only ones listening. Wall Street has its ear to the digital grapevine, too.
Pharma's social media evangelists have been urging companies to lend an ear to the chatter on Twitter, Facebook, patient forums, physician networking sites and the like. It's a way to engage with patients, monitor doctors' opinions, tailor marketing and spot safety concerns, they say.
The window for commenting on the FDA's draft guidance on pharma's use of Twitter and other social media slammed shut last week, leaving the agency with a stack of feedback to consider. Many of the respondents are unhappy with the draft, which was called unconstitutional and overbroad.
Chemisense is developing an updated air-quality monitor and correlating smartphone app that will identify areas with heavy pollutants and irritants for users, as well as crowdsource the data users collect.
With scholarly social network ResearchGate now adding 10,000 users a day to its network of 4.5 million researchers, the idea of a "Facebook for science" has finally taken off. But these numbers say nothing about whether people actually use the site and why, a shortcoming Nature has tried to fix by surveying thousands of researchers about their social media habits.
Apple released its newest operating system, iOS 8 beta 5, on Aug. 4. The system includes a number of health-related features such as icons for "Body Data" and "Data Exporting."
A Wall Street Journal feature this week on researchers' long-standing concerns about the consequences of patients talking about clinical trials online digs into how biopharma companies are tapping technology to counter concerns about unblinding and manipulating inclusion/exclusion criteria.
A wearable device for measuring exposure to ultraviolet light and a "smart" Kegel exercise aid recently created pages on Kickstarter requesting funders, highlighting the use of crowdfunding to back edgy new devices.
What's #FOGO? Hint: Many of us have it. Another hint: Pfizer wants people to talk about it.